Drug General Information
Drug ID	D0I3IG
Former ID	DAP001243
Drug Name	Alseroxylon
Indication	Hypertension [ICD9: 401; ICD10:I10-I16]		Approved	[550752]
Therapeutic Class	Antihypertensive Agents
Structure		Download 2D MOL
Formula	C33H40N2O9
CAS Number	CAS 8001-95-4
Target and Pathway
Target(s)	Synaptic vesicle amine transporter	Target Info	Blocker	[536284]
KEGG Pathway	Synaptic vesicle cycle
	Serotonergic synapse
	Dopaminergic synapse
	Parkinson's disease
	Cocaine addiction
	Amphetamine addiction
	Alcoholism
PANTHER Pathway	Adrenaline and noradrenaline biosynthesis
	5HT1 type receptor mediated signaling pathway
	5HT2 type receptor mediated signaling pathway
	5HT3 type receptor mediated signaling pathway
	5HT4 type receptor mediated signaling pathway
	Dopamine receptor mediated signaling pathway
	Nicotine pharmacodynamics pathway
	CCKR signaling map ST
Reactome	Norepinephrine Neurotransmitter Release Cycle
	Na+/Cl- dependent neurotransmitter transporters
WikiPathways	Dopaminergic Neurogenesis
	Synaptic Vesicle Pathway
	Neurotransmitter Release Cycle
	Nicotine Activity on Dopaminergic Neurons
References
Ref 550752	Drug information of Alseroxylon, 2008. eduDrugs.
Ref 536284	Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.